Primary Sclerosing Cholangitis: Therapeutic Options and Surveillance Management.

Clinical Medicine Insights. Gastroenterology Pub Date : 2016-06-09 eCollection Date: 2016-01-01 DOI:10.4137/CGast.S38451
Aditi Kumar, Daniel Wheatley, Amar Puttanna
{"title":"Primary Sclerosing Cholangitis: Therapeutic Options and Surveillance Management.","authors":"Aditi Kumar, Daniel Wheatley, Amar Puttanna","doi":"10.4137/CGast.S38451","DOIUrl":null,"url":null,"abstract":"<p><p>Primary sclerosing cholangitis is a chronic immune-mediated liver disease. Though rare, it poses several clinical concerns for the managing physician. There are currently limited therapeutic options in the management of the condition and weak evidence base behind them. Endoscopic intervention is limited to those patients with obstructing stricture-related disease, and even liver transplantation has a risk of disease recurrence. Surveillance for inflammatory bowel disorders, metabolic bone disease, and malignancy is paramount when managing such patients. This article provides an overview of the condition with further focus on current therapeutic options and guidance on surveillance management. </p>","PeriodicalId":10382,"journal":{"name":"Clinical Medicine Insights. Gastroenterology","volume":"9 ","pages":"25-9"},"PeriodicalIF":0.0000,"publicationDate":"2016-06-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4902039/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Medicine Insights. Gastroenterology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4137/CGast.S38451","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2016/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Primary sclerosing cholangitis is a chronic immune-mediated liver disease. Though rare, it poses several clinical concerns for the managing physician. There are currently limited therapeutic options in the management of the condition and weak evidence base behind them. Endoscopic intervention is limited to those patients with obstructing stricture-related disease, and even liver transplantation has a risk of disease recurrence. Surveillance for inflammatory bowel disorders, metabolic bone disease, and malignancy is paramount when managing such patients. This article provides an overview of the condition with further focus on current therapeutic options and guidance on surveillance management.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
原发性硬化性胆管炎:治疗方案和监控管理。
原发性硬化性胆管炎是一种免疫介导的慢性肝病。这种疾病虽然罕见,但却给主治医生带来了一些临床问题。目前,治疗该病的方法有限,而且证据基础薄弱。内镜干预仅限于那些患有阻塞性狭窄相关疾病的患者,即使是肝移植也有疾病复发的风险。在管理这类患者时,对炎症性肠道疾病、代谢性骨病和恶性肿瘤的监控至关重要。本文概述了这种疾病,并进一步重点介绍了当前的治疗方案和监控管理指南。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Clinical Medicine Insights. Gastroenterology
Clinical Medicine Insights. Gastroenterology GASTROENTEROLOGY & HEPATOLOGY-
自引率
0.00%
发文量
0
审稿时长
8 weeks
期刊最新文献
Biodegradable Stents in Resistant Peptic Oesophageal Stricture: Is It the Right Way to Go? Melanosis Coli: A Helpful Contrast Effect or a Harmful Pigmentation? Understanding Therapeutic Concepts in Crohn's Disease. The Benefits of Neuromuscular Electrical Stimulation in the Muscular and Functional Capacity of Patients With Liver Cirrhosis: Protocol for a Randomized Clinical Trial. Impact of Video Aid on Quality of Bowel Preparation Among Patients Undergoing Outpatient Screening Colonoscopy.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1